Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01346410 · ClinicalTrials.gov registry record · NA
Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer
A NA study, sponsored by Mercy Research.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01346410: Completed NA study, sponsored by Mercy Research.
NCT01346410 is a NA study that has completed, run by Mercy Research. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01346410, a NA study, has completed, sponsored by Mercy Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study will evaluate the local control rate as well as acute and late toxicity rates of stereotactic body radiotherapy (SBRT) for the treatment of unresectable pancreatic cancer.
Primary Outcome
Local recurrence is defined as tumor recurrence within the planning target volume. Local control rate will be evaluated by imaging techniques such as CT or MRI. Local recurrence will be defined as an increase of \> 20% in tumor size. If necessary, a Positron Emission Tomography scan may be used to aid in diagnoses of local tumor recurrence.
Interventions
- RADIATION Stereotactic Body Radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-09 |
| Est. Completion | 2012-07 |
| Phase | NA |
What the finished NCT01346410 record still lists
NCT01346410 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Stereotactic Body Radiotherapy is the first listed.
NCT01346410 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01346410 about?
NCT01346410 is a clinical study titled "Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer". This study will evaluate the local control rate as well as acute and late toxicity rates of stereotactic body radiotherapy (SBRT) for the treatment of unresectable pancreatic cancer.
What is the current status of trial NCT01346410?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2008-09. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01346410?
The interventions under investigation include: Stereotactic Body Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT01346410?
This trial is sponsored by Mercy Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01346410's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia